Molnupiravir21 Oct 2021 07:04
https://www.barrons.com/articles/merck-covid-pill-risks-51633398722
Barron’s reported on Oct. 5 that molnupiravir’s efficacy was not all roses, as it had shown to be mutagenic in mammalian cells, “Molnupiravir works by incorporating itself into the genetic material of the virus, and then causing a huge number of mutations as the virus replicates, effectively killing it,” reads the article.
“In some lab tests, the drug has also shown the ability to integrate into the genetic material of mammalian cells, causing mutations as those cells replicate.”
Raymond Schinazi, a professor at the same Emory University where molnupiravir was developed, told the outlet, “Proceed with caution and at your own peril.”
According to Barron’s, Schinazi, who was not involved in the development of molnupiravir, has studied NHC, the active compound that the Merck pill synthesizes in the body to produce its antiviral effect, for decades.
Schinazi was further paraphrased as stating that “he did not believe that molnupiravir should be given to pregnant women, or to young people of reproductive age, until more data is available.”